PATENT CLAIM ANALYSIS

Application Number: 16078431
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "304000"]

Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver diseases and disorders.

Claim (Index 8):
A pharmaceutical unit dosage form composition comprising about 10 \u03bcg, about 30 \u03bcg, about 60 \u03bcg or about 90 \u03bcg of Compound A suitable for oral administration up to a maximum total dose of about 100 \u03bcg per day.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 96.0
- Lexical Diversity: 1.03333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14012401', '11819517', '15263033', '16030141', '14743295']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7585329311040305
- 35 USC 102 Novelty (BERT): 0.5035625343643869
- Combined Prediction Score: 0.7330358914300662
- Mean Citation Score: 248.90263
- Max Citation Score: 260.66025
- Similarity Product: 186.04184229692817

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test